会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • 8-alkylthio-2-piperazino-pyrimido[5,4-d]-pyrimidines
    • 8-烷硫基-2-哌嗪基 - 嘧啶并[5,4-d] - 嘧啶
    • US4714698A
    • 1987-12-22
    • US745095
    • 1985-06-17
    • Josef RochArmin HeckelJosef NicklErich MullerBerthold NarrRainer ZimmermannJohannes Weisenberger
    • Josef RochArmin HeckelJosef NicklErich MullerBerthold NarrRainer ZimmermannJohannes Weisenberger
    • A61K31/505A61K31/55A61P7/02A61P9/10A61P35/00C07D487/04C07D471/04
    • C07D487/04
    • The invention relates to new compounds of general formula ##STR1## wherein R.sub.1 represents an alkyl group,R.sub.2 represents a hydrogen atom, an alkyl group optionally substituted (except at the .alpha. carbon atom) by a hydroxy group, or represents a cycloalkyl group or an allyl, phenyl or benzyl group,R.sub.3 represents an allyl group, an alkyl group optionally substituted (except at the .alpha. carbon atom) by a hydroxy group, or represents a cycloalkyl group orR.sub.2 and R.sub.3 together with the nitrogen atom between them represent a straight-chained alkyleneimino group,the acid addition salts thereof, particularly the acid addition salts thereof with physiologically acceptable inorganic or organic acids which have valuable pharmacological properties, particularly a metastasis-inhibiting effect based on their selective tumour-PDE inhibiting effect, and pharmaceutical compositions containing these compounds or the physiologically acceptable acid addition salts thereof.The new compounds may be prepared according to methods known for analogous compounds.
    • 本发明涉及通式(I)的新化合物,其中R 1表示烷基,R 2表示氢原子,任选被羟基取代的烷基(除了在α碳原子上),或表示环烷基 基团或烯丙基,苯基或苄基,R 3表示烯丙基,任选被羟基取代的烷基(除了在α碳原子上),或表示环烷基或R 2和R 3以及它们之间的氮原子 代表直链亚烷基亚氨基,其酸加成盐,特别是其酸加成盐与具有有价值的药理学性质的生理上可接受的无机或有机酸,特别是基于其选择性肿瘤-PDE抑制作用的转移抑制作用,以及 含有这些化合物的药物组合物或其生理上可接受的酸加成盐。 新化合物可以根据类似化合物已知的方法制备。
    • 10. 发明授权
    • 3-Amino-4-phenyl-1H-pyrazolo[3,4-b]pyridines and salts thereof
    • 3-氨基-4-苯基-1H-吡唑并[3,4-b]吡啶及其盐
    • US4182887A
    • 1980-01-08
    • US834114
    • 1977-09-19
    • Josef RochErich MullerBerthold NarrJosef NicklWalter Haarmann
    • Josef RochErich MullerBerthold NarrJosef NicklWalter Haarmann
    • A61K31/435A61P7/02A61P29/00C07D213/85C07D471/04
    • C07D471/04C07D213/85Y10S514/822
    • Compounds of the formula ##STR1## wherein R.sub.1 is mono- or di-substituted amino, where the substituents are selected from the group consisting of alkyl of 1 to 6 carbon atoms, cyclohexyl, allyl and benzyl; unsubstituted, mono-substituted or di-substituted pyrrolidino, piperidino, hexamethyleneimino, morpholino, piperazino, thiomorpholino, 1-oxido-thiomorpholino or 1,1-dioxido-thiomorpholino, where the substituents are selected from the group consisting of methyl, hydroxymethyl, hydroxyl, phenyl and benzyl; 1,2,5,6-tetrahydropyridino; 1,2,3,4-tetrahydroisoquinolino; indolino; or 3,6-ethylene-hexamethyleneimino;R.sub.2 is hydrogen, methyl or benzyl; andR.sub.3 is hydrogen, halogen, alkyl of 1 to 3 carbon atoms or alkoxy of 1 to 3 carbon atoms;and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as antiphlogistics and antithrombotics.
    • 其中R 1是单取代或二取代的氨基,其中取代基选自1至6个碳原子的烷基,环己基,烯丙基和苄基; 未取代的单取代或二取代的吡咯烷子基,哌啶子基,六亚甲基亚氨基,吗啉代,哌嗪子基,硫代吗啉代,1-氧代硫代吗啉代或1,1-二氧化硫代吗啉代,其中取代基选自甲基,羟甲基,羟基 ,苯基和苄基; 1,2,5,6-四氢吡啶子; 1,2,3,4-四氢异喹啉; indolino; 或3,6-亚乙基 - 六亚甲基亚氨基; R2是氢,甲基或苄基; R3为氢,卤素,1〜3个碳原子的烷基或1〜3个碳原子的烷氧基; 和无毒的,药学上可接受的酸加成盐。 化合物及其盐可用作消炎和抗血栓形成。